关注
Xiaomeng Wan
标题
引用次数
引用次数
年份
A high capacity polymeric micelle of paclitaxel: Implication of high dose drug therapy to safety and in vivo anti-cancer activity
Z He, X Wan, A Schulz, H Bludau, MA Dobrovolskaia, ST Stern, ...
Biomaterials 101, 296-309, 2016
1842016
Co-delivery of paclitaxel and cisplatin in poly (2-oxazoline) polymeric micelles: Implications for drug loading, release, pharmacokinetics and outcome of ovarian and breast …
X Wan, JJ Beaudoin, N Vinod, Y Min, N Makita, H Bludau, R Jordan, ...
Biomaterials, 2018
1822018
Drug Combination Synergy in Worm-like Polymeric Micelles Improves Treatment Outcome for Small Cell and Non-Small Cell Lung Cancer
X Wan, Y Min, H Bludau, A Keith, SS Sheiko, R Jordan, AZ Wang, ...
ACS nano, 2018
1452018
Poly (2-oxazoline) based micelles with high capacity for 3rd generation taxoids: Preparation, in vitro and in vivo evaluation
Z He, A Schulz, X Wan, J Seitz, H Bludau, DY Alakhova, DB Darr, ...
Journal of Controlled Release 208, 67-75, 2015
1102015
Poly (2‐oxazoline) block copolymer based formulations of taxanes: effect of copolymer and drug structure, concentration, and environmental factors
Y Seo, A Schulz, Y Han, Z He, H Bludau, X Wan, J Tong, TK Bronich, ...
Polymers for Advanced Technologies 26 (7), 837-850, 2015
742015
Nanoparticle delivery of chemotherapy combination regimen improves the therapeutic efficacy in mouse models of lung cancer
J Tian, Y Min, Z Rodgers, X Wan, H Qiu, Y Mi, X Tian, KT Wagner, ...
Nanomedicine: Nanotechnology, Biology and Medicine 13 (3), 1301-1307, 2017
272017
A High Performance Liquid Chromatography Method for the Quantitative Determination Assay of Sitagliptin in Rat Plasma and Its Application in Pharmacokinetics Study
WL Xiangfei Jiu, Dewei Shang, Ye Chen, Xingang Li, Xiaomeng Wan, Tianyan Zhou
Journal of Chinese Pharmaceutical Sciences 20 (1), 63-69, 2011
252011
Poly (2-Oxazoline) Micellar Formulation For Cancer Therapy
X Wan
The University of North Carolina at Chapel Hill, 2018
2018
Tumor inhibition of poly (2-oxazoline)-paclitaxel formulations in advanced tumor models evaluated against clinical paclitaxel formulations
R Luxenhofer, Z He, A Schulz, X Wan, R Jordan, A Kabanov
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY 252, 2016
2016
系统目前无法执行此操作,请稍后再试。
文章 1–9